Page last updated: 2024-09-03

y 27632 and Carcinoma, Transitional Cell

y 27632 has been researched along with Carcinoma, Transitional Cell in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hutchinson, RC; Krabbe, LM; Margulis, V; Sanli, O; Woldu, SL	1
Boergermann, C; Jakobs, KH; Lümmen, G; Rübben, H; Sanders, H; Schmidt, M; vom Dorp, F	1
Chang, HR; Huang, HP; Hung, TW; Lian, JD; Tsai, JP; Wang, CJ; Wu, SW	1

Reviews

1 review(s) available for y 27632 and Carcinoma, Transitional Cell

Article	Year
The Rho GTPase signalling pathway in urothelial carcinoma. Nature reviews. Urology, 2018, Volume: 15, Issue:2 Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Camellia sinensis; Carcinoma, Transitional Cell; Enzyme Inhibitors; Humans; Neoplasm Metastasis; Plant Extracts; Protein Kinase Inhibitors; Pyridines; rho GTP-Binding Proteins; rho-Associated Kinases; Signal Transduction; Urinary Bladder Neoplasms	2018

Article

Year

The Rho GTPase signalling pathway in urothelial carcinoma.

Nature reviews. Urology, 2018, Volume: 15, Issue:2

Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Camellia sinensis; Carcinoma, Transitional Cell; Enzyme Inhibitors; Humans; Neoplasm Metastasis; Plant Extracts; Protein Kinase Inhibitors; Pyridines; rho GTP-Binding Proteins; rho-Associated Kinases; Signal Transduction; Urinary Bladder Neoplasms

2018

Other Studies

2 other study(ies) available for y 27632 and Carcinoma, Transitional Cell

Article	Year
Inhibition of Rho-kinase abrogates migration of human transitional cell carcinoma cells: results of an in vitro study. Urologia internationalis, 2011, Volume: 86, Issue:2 Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Actins; Amides; Bacterial Proteins; Bacterial Toxins; Calcium; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Movement; Fura-2; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Lysophospholipids; Mutation; Pertussis Toxin; Phalloidine; Protein Kinase Inhibitors; Pyridines; rho GTP-Binding Proteins; rho-Associated Kinases; Type C Phospholipases	2011
Y27632 attenuates the aristolochic acid-promoted invasion and migration of human urothelial cancer TSGH cells in vitro and inhibits the growth of xenografts in vivo. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2012, Volume: 27, Issue:2 Topics: Amides; Animals; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Mice, Nude; Plant Extracts; Pyridines; Random Allocation; Real-Time Polymerase Chain Reaction; Reference Values; RNA, Messenger; Sensitivity and Specificity; Transplantation, Heterologous; Urokinase-Type Plasminogen Activator	2012

Article

Year

Inhibition of Rho-kinase abrogates migration of human transitional cell carcinoma cells: results of an in vitro study.

Urologia internationalis, 2011, Volume: 86, Issue:2

Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Actins; Amides; Bacterial Proteins; Bacterial Toxins; Calcium; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Movement; Fura-2; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Lysophospholipids; Mutation; Pertussis Toxin; Phalloidine; Protein Kinase Inhibitors; Pyridines; rho GTP-Binding Proteins; rho-Associated Kinases; Type C Phospholipases

2011

Y27632 attenuates the aristolochic acid-promoted invasion and migration of human urothelial cancer TSGH cells in vitro and inhibits the growth of xenografts in vivo.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2012, Volume: 27, Issue:2

Topics: Amides; Animals; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Mice, Nude; Plant Extracts; Pyridines; Random Allocation; Real-Time Polymerase Chain Reaction; Reference Values; RNA, Messenger; Sensitivity and Specificity; Transplantation, Heterologous; Urokinase-Type Plasminogen Activator

2012